Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has issued a correction disclosure to announce the contract end date as March 31, 2025, following the completion of performance under its pharmaceutical contract manufacturing agreement with Cilag GmbH International.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: (Correction) Single Sales and Supply Contract
- Original Filing Date: December 30, 2022 (Initial filing date: November 16, 2016)
- Reason for Correction: Disclosure of the contract end date following completion of contract performance
- Key Correction Items:
- Contract End Date: (Before) Undisclosed (Scheduled for disclosure after 2025-12-31) ➔ (After) March 31, 2025
- Confidentiality Reason & Expiration Date: (Before) Business confidentiality / 2025-12-31 ➔ (After) Not stated (-)
- Contract Details (As Revised in Filing):
- Contract Classification & Title: Other Sales/Supply Contract (Pharmaceutical Contract Manufacturing Agreement)
- Contract Amount: KRW 436,017,975,914 (USD 373,047,549.55, applied exchange rate KRW 1,168.80 per USD on initial disclosure date Nov 16, 2016)
- Recent Annual Revenue: KRW 91,278,028,788 (Based on FY2015 revenue at time of initial disclosure)
- Contract Amount to Revenue Ratio: 477.68%
- Counterparty: Cilag GmbH International
- Contract Period: November 15, 2016 – March 31, 2025
- Contract Date: November 15, 2016
- Other Important Details:
- The contract amount reflects an increase of USD 81,259,297.76 from the previously disclosed amount (USD 291,788,251.79) to USD 373,047,549.55 upon customer request, applied with the exchange rate from the initial filing.
- Related Disclosures:
- November 16, 2016: Single Sales and Supply Contract
- December 30, 2019: Single Sales and Supply Contract
- July 06, 2020: Single Sales and Supply Contract
- December 30, 2022: Single Sales and Supply Contract
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Contract End Date Disclosure Following Completion of Performance
This correction disclosure provides notice that the contract manufacturing agreement with Cilag GmbH International has been completed, resulting in the disclosure of the contract end date.
Checking the disclosed contract end date (March 31, 2025) and the updated contract period details (Nov 15, 2016 – Mar 31, 2025) is essential.
Relevant details can be verified in subsequent periodic filings and official disclosures.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
